Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice
Doris Kaltenecker, Madeleine Themanns, Kristina M. Mueller, et al.
Cytokine (2018) Vol. 124, pp. 154573-154573
Open Access | Times Cited: 14

Showing 14 citing articles:

JAK/STAT signaling in hepatocellular carcinoma
Justin Jit Hin Tang, Dexter Kai Hao Thng, Jhin Jieh Lim, et al.
Hepatic Oncology (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 125
Mechanisms and therapeutic prospect of the JAK-STAT signaling pathway in liver cancer
Junjun Jia, Xuelian Zhou, Qingfei Chu
Molecular and Cellular Biochemistry (2024) Vol. 480, Iss. 1, pp. 1-17
Closed Access | Times Cited: 11
Cooperative STAT3-NFkB signaling modulates mitochondrial dysfunction and metabolic profiling in hepatocellular carcinoma
Sharmeen Ishteyaque, Gurvinder Singh, Karan Singh Yadav, et al.
Metabolism (2024) Vol. 152, pp. 155771-155771
Closed Access | Times Cited: 10
Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes
Arturo Valle‐Mendiola, Isabel Soto‐Cruz
Cancers (2020) Vol. 12, Iss. 1, pp. 124-124
Open Access | Times Cited: 62
Hepatic growth hormone - JAK2 - STAT5 signalling: Metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression
Doris Kaltenecker, Madeleine Themanns, Kristina M. Mueller, et al.
Cytokine (2018) Vol. 124, pp. 154569-154569
Open Access | Times Cited: 60
Balancing STAT Activity as a Therapeutic Strategy
Kelsey L. Polak, Noah M. Chernosky, Jacob Smigiel, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1716-1716
Open Access | Times Cited: 22
<p>STAT gene family mRNA expression and prognostic value in hepatocellular carcinoma</p>
Zhitao Dong, Yi Chen, Cheng Yang, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 7175-7191
Open Access | Times Cited: 21
Dietary Restriction Suppresses Steatosis-Associated Hepatic Tumorigenesis in Hepatitis C Virus Core Gene Transgenic Mice
Fangping Jia, Pan Diao, Xiaojing Wang, et al.
Liver Cancer (2020) Vol. 9, Iss. 5, pp. 529-548
Open Access | Times Cited: 16
MEHP promotes liver fibrosis by down-regulating STAT5A in BRL-3A hepatocytes
Yuezhu Zhang, Hui Ju, Yan Xu, et al.
Chemosphere (2022) Vol. 295, pp. 133925-133925
Closed Access | Times Cited: 10
Liver-specific deletion of miR-181ab1 reduces liver tumour progression via upregulation of CBX7
Jinbiao Chen, Yang Zhao, Fan Zhang, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 10
STAT5 inhibitor attenuates atherosclerosis via inhibition of inflammation: the role of STAT5 in atherosclerosis.
Xiaodong Wang, Ding Xiao-ji, Jin Yan, et al.
(2021) Vol. 13, Iss. 3, pp. 1422-1431
Closed Access | Times Cited: 13
GH-dependent growth of experimentally induced carcinomas in vivo
Paul C. Marker, Christopher J Unterberger, Steven M. Swanson
Endocrine Related Cancer (2023) Vol. 30, Iss. 5
Open Access | Times Cited: 2
Editorial: Cytokines in liver diseases
Subburaj Ilangumaran, Richard Moriggl, Dhan V. Kalvakolanu
Cytokine (2018) Vol. 124, pp. 154608-154608
Closed Access | Times Cited: 2
Prognostic significance ofSOCS1andSOCS3tumor suppressors in hepatocellular carcinoma and its correlation to key oncogenic signaling pathways
Md Gulam Musawwir Khan, Amit Ghosh, Bhavesh Varia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access
Page 1

Scroll to top